Publications
- Ruthenium(II) Complex Containing a Redox-Active Semiquinonate Ligand as a Potential Chemotherapeutic Agent: From Synthesis to In Vivo Studies2020 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Novel quinazolin-4-one derivatives as potentiating agents of doxorubicin cytotoxicity2019 | Faculty of Medicine in Hradec Králové
- Anticancer potential of Amaryllidaceae alkaloids evaluated by screening with a panel of human cells, real-time cellular analysis and Ehrlich tumor-bearing mice2017 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- The effects of beta-caryophyllene oxide and trans-nerolidol on the efficacy of doxorubicin in breast cancer cells and breast tumor-bearing mice2017 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- In-vitro and in-vivo evaluation of the anticancer activity of diruthenium-2, a new trithiolato arene ruthenium complex [(eta(6)-p-MeC6H4Pri)(2)Ru-2(mu-S-p-C6H4OH)(3)]Cl2016 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Pharmacokinetics of Boldine in Control and Mrp2-Deficient Rats2016 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- The Steroidal Glycoalkaloids from Solanaceae: Toxic Effect, Antitumour Activity and Mechanism of Action2016 | Faculty of Medicine in Hradec Králové
- Boldine Inhibits Mouse Mammary Carcinoma In Vivo and Human MCF-7 Breast Cancer Cells In Vitro2016 | Faculty of Medicine in Hradec Králové
- Chlorambucil conjugates of dinuclear p-cymene ruthenium trithiolato complexes: synthesis, characterization and cytotoxicity study in vitro and in vivo2016 | Faculty of Medicine in Hradec Králové
- Boldine enhances bile production in rats via osmotic and Farnesoid X receptor dependent mechanisms2015 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
Loading network view...